Chimeric Antigen Receptor (CAR) T-cell Immunotherapy for Hepatocellular Carcinoma: A Review of Current Progress and Challenges. Int J Mod Med. 2025;4(06):1-7. Accessed November 1, 2025. http://www.intjmm.com/index.php/ijmm/article/view/64